Biodesix (BDSX) Income from Continuing Operations (2019 - 2026)

Biodesix (BDSX) has 8 years of Income from Continuing Operations data on file, last reported at 8499000.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 21.46% year-over-year to 8499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 88388000.0 (down 120.83% YoY) and the FY2025 annual result came in at 134398000.0, down 0.68% from the prior year.
• Income from Continuing Operations retreated to 8499000.0 in Q1 2026, from 4026000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 4026000.0 in Q4 2025 to a low of 64637000.0 in Q1 2023.
• A 5-year average of 21615058.82 and a median of 13165000.0 in 2023 frame the typical range for Income from Continuing Operations.
• Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 79.04% — and 2025, when it sank 412.78%.
• Tracing BDSX's Income from Continuing Operations over 5 years: stood at 9377000.0 in 2022, then tumbled by 40.4% to 13165000.0 in 2023, then surged by 36.19% to 8401000.0 in 2024, then surged by 52.08% to 4026000.0 in 2025, then plunged by 111.1% to 8499000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 8499000.0 (Q1 2026), 4026000.0 (Q4 2025), and 23703000.0 (Q3 2025), per Business Quant data.